Patent details

Basic Information

Publication number:

EP3663399

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP192186369

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF

French Title of Invention:

POLYPEPTIDES DU FACTEUR IX MODIFIÉS ET LEURS UTILISATIONS

German Title of Invention:

MODIFIZIERTE FAKTOR-IX-POLYPEPTIDE UND IHRE VERWENDUNGEN

SPC Number:

Dates

Filing date:

03/11/2011

Grant date:

22/12/2021

EP Publication Date:

10/06/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/12/2021

EP B1 Publication Date:

22/12/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/11/2022

Expiration date:

03/11/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/12/2021

 

 

Name:

Catalyst Biosciences, Inc.

Address:

611 Gateway Blvd., Suite 710, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:

BLOUSE, Grant Ellsworth

Address:

United States (US)

2

Name:

MADISON, Edwin L

Address:

United States (US)

3

Name:

THANOS, Christopher

Address:

United States (US)

Priority

Priority Number:

45629810 P

Priority Date:

03/11/2010

Priority Country:

United States (US)

Classification

IPC classification:

C12N 9/64; C12N 15/55; A61K 38/43;

Publication

European Patent Bulletin

Issue number:

202151

Publication date:

22/12/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages